ANGEL LUIS
GUERRERO PERAL
PROFESOR ASOCIADO CIENCIAS DE LA SALUD
Fundación Hospital Alcorcón
Alcorcón, EspañaFundación Hospital Alcorcón -ko ikertzaileekin lankidetzan egindako argitalpenak (8)
2024
-
Effectiveness, tolerability, and response predictors of preventive anti-CGRP mAbs for migraine in patients over 65 years old: a multicenter real-world case-control study
Pain Medicine (United States), Vol. 25, Núm. 3, pp. 194-202
-
Evaluation of the concomitant use of prophylactic treatments in patients with migraine under anti-calcitonin gene-related peptide therapies: The PREVENAC study
European Journal of Neurology, Vol. 31, Núm. 5
-
Long-term safety of OnabotulinumtoxinA treatment in chronic migraine patients: a five-year retrospective study
Frontiers in Neurology , Vol. 15
2022
-
Machine-learning-based approach for predicting response to anti-calcitonin gene-related peptide (CGRP) receptor or ligand antibody treatment in patients with migraine: A multicenter Spanish study
European Journal of Neurology, Vol. 29, Núm. 10, pp. 3102-3111
2019
-
Catechol-O-Methyltransferase (COMT) rs4680 Val158Met Polymorphism is Associated With Widespread Pressure Pain Sensitivity and Depression in Women With Chronic, but not Episodic, Tension-Type Headache
Clinical Journal of Pain, Vol. 35, Núm. 4, pp. 345-352
2016
-
Epicrania Fugax
Current Pain and Headache Reports, Vol. 20, Núm. 4, pp. 1-7
2015
-
Idiopathic ophthalmodynia and idiopathic rhinalgia: A prospective series of 16 new cases
Headache, Vol. 55, Núm. 10, pp. 1430-1435